Neuropeptide-Y
神经肽Y
Report date: 2022/03/09 14:51:47
Base Information
Drug NameNeuropeptide-Y
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Texas Southwestern Medical Center
China Registration ClassN/A
Develop Information
Active CompaniesUniversity of Texas Southwestern Medical Center
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A